Biocompatible molecularly imprinted polynorepinephrine nanoparticles: rational design and one-step reversible immobilization for enhanced protein recognition by surface plasmon resonance
Microchimica Acta · 2026
DOI: 10.1007/s00604-026-07893-z ↗Kurz gefasst
Fachartikel in der Zeitschrift Microchimica Acta, 2026. Verfasst von Simone Ventisette und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry "Ugo Schiff', University of Florence, Via della Lastruccia, 3-13, 50019, Sesto Fiorentino, Italy. Hauptthemen laut MEDLINE: Surface Plasmon Resonance, Molecular Imprinting, Immunoglobulin G, Norepinephrine. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Firenze.
Abstract (Originalsprache)
Polynorepinephrine nanoparticles (PNE-NPs) are emerging bioinspired nanomaterials with significant potential in diagnostics and therapy, yet their systematic synthesis and functional assessment remain limited. In this work, a Design of Experiments approach was applied to optimize the synthesis of non-imprinted and imprinted PNE-NPs. A green, pH-triggered precipitation/redispersion protocol was introduced for nanoparticle purification, providing fast and reproducible recovery without organic solvents, and surpassing conventional membrane dialysis methods, which are typically long and labor-intensive. Key parameters (pH, temperature, reaction time, stirring, and monomer concentration) were screened in H2O/NaOH and TRIS buffer media. Optimized PNE-NPs displayed hydrodynamic diameters below 200 nm, spherical morphology, and negligible cytotoxicity in HaCaT keratinocytes across a broad concentration range. As a model study, PNE-NPs were imprinted against the Fc portion of human IgG1 and tested as synthetic receptors by surface plasmon resonance (SPR). Two flow-mode immobilization strategies were compared on bare gold chips: covalent grafting on thiol-modified gold and direct adsorption. Both allowed real-time, in-flow monitoring and markedly improved affinity (KD 27.4), and full in situ reconditioning of the SPR gold transducer with NaClO washes, enabling multiple reuse cycles. These results establish PNE-NPs as versatile synthetic receptors, highlighting their promise as next-generation platforms for diagnostics and therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry "Ugo Schiff', University of Florence, Via della Lastruccia, 3-13, 50019, Sesto Fiorentino, Italy.
- Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126, Pisa, Italy.
- Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126, Pisa, Italy. maria.minunni@unipi.it.
- Department of Chemistry "Ugo Schiff', University of Florence, Via della Lastruccia, 3-13, 50019, Sesto Fiorentino, Italy. simona.scarano@unifi.it.
Förderung
- Università degli Studi di Firenze
Zitieren
APA
Ventisette, S., Galgani, G., Palladino, P., Calderone, V., Citi, V., Minunni, M., & Scarano, S. (2026). Biocompatible molecularly imprinted polynorepinephrine nanoparticles: rational design and one-step reversible immobilization for enhanced protein recognition by surface plasmon resonance. Microchimica Acta. https://doi.org/10.1007/s00604-026-07893-z
Vancouver
Ventisette S, Galgani G, Palladino P, Calderone V, Citi V, Minunni M, et al. Biocompatible molecularly imprinted polynorepinephrine nanoparticles: rational design and one-step reversible immobilization for enhanced protein recognition by surface plasmon resonance. Microchimica Acta. 2026. doi:10.1007/s00604-026-07893-z
BibTeX
@article{Ventisette2026,
author = {Ventisette, Simone and Galgani, Giulia and Palladino, Pasquale and Calderone, Vincenzo and Citi, Valentina and Minunni, Maria and Scarano, Simona},
title = {Biocompatible molecularly imprinted polynorepinephrine nanoparticles: rational design and one-step reversible immobilization for enhanced protein recognition by surface plasmon resonance},
journal = {Microchimica Acta},
year = {2026},
doi = {10.1007/s00604-026-07893-z}
}
EUVIMED